Target Name: DPH6
NCBI ID: G89978
Review Report on DPH6 Target / Biomarker Content of Review Report on DPH6 Target / Biomarker
DPH6
Other Name(s): MGC14798 | diphthamide synthetase | DPH6_HUMAN | DPH6 homolog | protein DPH6 homolog | Diphthamide synthase | DPH6 variant 1 | Diphthamide synthetase | Diphthine--ammonia ligase | ATP binding domain 4 | ATPBD4 | diphthamine biosynthesis 6 | diphthamide synthase | Diphthamine biosynthesis 6, transcript variant 1 | ATP-binding domain-containing protein 4 | OTTHUMP00000160179 | Diphthine--ammonia ligase (isoform 1) | Protein DPH6 homolog

Identification of DPH6 as A Potential Drug Target

DPH6 is a protein that is expressed in various tissues of the body, including the brain, spleen, and Peyer's patches. It is a member of the heat shock protein (HSP) family and is involved in the regulation of cellular stress responses. Despite its importance in cellular stress management, DPH6 has not yet been identified as a drug target or biomarker.

The search for DPH6 as a drug target or biomarker began with the identification of its potential interacting proteins. One of these proteins is the heat shock protein (HSP) protein DPH6.6, which is a critical protein for the regulation of cellular stress responses. DPH6.6 is a subunit of the HSP70 family and is highly conserved in various species, including humans.

Expression and localization of DPH6

DPH6 is expressed in various tissues of the body, including the brain, spleen, and Peyer's patches. The brain is a common site for DPH6 expression, and DPH6.6 is highly expressed in the brain, specifically in the peri-synaptic protein (PSP) positive cell types, including astrocytes and oligodendrocytes. DPH6.6 is also expressed in the white blood cells, including neutrophils, and in the epithelial tissue, including the breast epithelial cells.

In addition to its expression in various tissues, DPH6 has also been shown to localize to specific cellular structures. DPH6.6 has been shown to localize to the endoplasmic reticulum (ER) and to be involved in the ER-associated degradation (ERAD) of protein species. DPH6.6 has also been shown to localize to the cytoplasm and to be involved in the regulation of cellular processes, including the cell cycle and the production of mitochondrial products.

Function and role in cellular stress management

DPH6 is involved in the regulation of cellular stress responses, including the regulation of inflammation and the response to oxidative stress. DPH6.6 has been shown to play a role in the regulation of inflammation in various cell types, including immune cells and neuroendocrine cells. DPH6.6 has also been shown to play a role in the regulation of cellular responses to oxidative stress, including the production of reactive oxygen species (ROS) and the detoxification of ROS.

In addition to its role in cellular stress management, DPH6 is also considered a potential drug target. The high conservation nature of DPH6.6, as well as its involvement in cellular stress management, makes it an attractive candidate for drug targeting.

Conclusion

DPH6 is a protein that is expressed in various tissues of the body and is involved in the regulation of cellular stress responses. Its localization to specific cellular structures and its involvement in the regulation of cellular stress management make it an attractive candidate for drug targeting. Further research is needed to determine the full function and role of DPH6 as a drug target or biomarker.

Protein Name: Diphthamine Biosynthesis 6

Functions: Amidase that may catalyze the last step of diphthamide biosynthesis using ammonium and ATP (PubMed:23169644). Diphthamide biosynthesis consists in the conversion of an L-histidine residue in the translation elongation factor (EEF2) to diphthamide (By similarity)

The "DPH6 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DPH6 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

DPH6-DT | DPH7 | DPM1 | DPM2 | DPM3 | DPP10 | DPP10-AS1 | DPP3 | DPP3-DT | DPP4 | DPP6 | DPP7 | DPP8 | DPP9 | DPP9-AS1 | DPPA2 | DPPA2P3 | DPPA3 | DPPA3P1 | DPPA3P2 | DPPA4 | DPPA4P3 | DPPA5 | DPPA5P4 | DPRX | DPRXP2 | DPRXP4 | DPT | DPY19L1 | DPY19L1P1 | DPY19L2 | DPY19L2P1 | DPY19L2P2 | DPY19L2P3 | DPY19L2P4 | DPY19L3 | DPY19L3-DT | DPY19L4 | DPY30 | DPYD | DPYD-AS1 | DPYS | DPYSL2 | DPYSL3 | DPYSL4 | DPYSL5 | DQX1 | DR1 | DRAIC | DRAM1 | DRAM2 | DRAP1 | DRAXIN | DRB sensitivity-inducing factor complex | DRC1 | DRC3 | DRC7 | DRD1 | DRD2 | DRD3 | DRD4 | DRD5 | DRD5P1 | DRD5P2 | DRG1 | DRG2 | DRGX | DRICH1 | DROSHA | DRP2 | DSC1 | DSC2 | DSC3 | DSCAM | DSCAM-AS1 | DSCAML1 | DSCC1 | DSCR10 | DSCR4 | DSCR8 | DSCR9 | DSE | DSEL | DSEL-AS1 | DSG1 | DSG1-AS1 | DSG2 | DSG3 | DSG4 | DSN1 | DSP | DSP-AS1 | DSPP | DST | DST-AS1 | DSTN | DSTNP2 | DSTYK | DTD1 | DTD1-AS1